Jinhe Good Will from 2010 to 2025

002688 Stock   4.33  0.03  0.69%   
Jinhe Biotechnology's Good Will is increasing over the years with slightly volatile fluctuation. Good Will is expected to dwindle to about 314.3 M. Good Will is an intangible asset that arises when Jinhe Biotechnology Co acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors. View All Fundamentals
 
Good Will  
First Reported
2014-12-31
Previous Quarter
496.7 M
Current Value
495.2 M
Quarterly Volatility
127.6 M
 
Yuan Drop
 
Covid
Check Jinhe Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jinhe Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 20.8 M, Selling General Administrative of 167.5 M or Total Revenue of 1.5 B, as well as many indicators such as . Jinhe financial statements analysis is a perfect complement when working with Jinhe Biotechnology Valuation or Volatility modules.
  
This module can also supplement various Jinhe Biotechnology Technical models . Check out the analysis of Jinhe Biotechnology Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Jinhe Stock

Jinhe Biotechnology financial ratios help investors to determine whether Jinhe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jinhe with respect to the benefits of owning Jinhe Biotechnology security.